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ORIGINAL RESEARCH • MUSCULOSKELETAL IMAGING
Many patients with radicular pain due to nerve root com-pression or low back pain related to degeneration of 
the facet joint respond favorably to imaging-guided spinal 
therapeutic injections with steroids (1–3). Lumbar transfo-
raminal epidural and lumbar facet joint steroid injections 
can be performed reliably, safely, and quickly with either a 
fluoroscopy-guided or CT-guided technique (4–6).
However, it is unknown how the amount of radiation 
dose exposure differs between patients and the physicians 
performing the procedures, if at all. Moreover, it has not 
been specifically studied whether fluoroscopy-guided in-
jections yield more favorable clinical patient outcomes 
than CT-guided lumbar spinal therapeutic injections or 
vice versa. Thus, we hypothesized that the radiation expo-
sure for patients and interventional physicians is different 
between these two techniques. Our second hypothesis was 
that patient clinical outcomes after imaging-guided lumbar 
spinal therapeutic injections with long-acting steroids may 
be influenced by the chosen imaging-guided technique.
Thus, the aims of our observational study were to 
compare (a) the procedure-related radiation exposure for 
participants and interventionalists and (b) the clinical out-
comes of participants with fluoroscopy-guided and CT-
guided lumbar spinal injections.
Materials and Methods
Participants
Institutional review board approval was obtained for this 
single-institution prospective observational study (EK-
12/2009, EK-22/2009). Written informed consent and 
permission to use the participants’ data for scientific pur-
poses were obtained before the intervention. Participants 
were informed about the procedure and the associated risks 
and benefits of the lumbar spinal injections.
Between October 2009 and April 2016, 1446 par-
ticipants received transforaminal epidural injections or 
facet joint injections under fluoroscopic or CT guidance 
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Purpose: To compare the radiation exposure for participants and interventionalists as well as participant outcomes between fluoros-
copy-guided versus CT-guided lumbar spinal injections.
Materials and Methods: This prospective, nonrandomized observational study included 1446 participants (mean age, 60.6 years; 
range, 18–91 years) who received transforaminal epidural injections or facet joint injections under fluoroscopic or CT guidance be-
tween October 2009 and April 2016. Effective doses were estimated by conversion from dose-area product for fluoroscopy-guided 
injections and dose-length product for CT-guided injections. Radiation exposure for interventionalists was measured with dosim-
eters at the body and wrist. The Patient Global Impression of Change (PGIC) scale was used to assess clinical participant outcomes 
at 1 day, 1 week, and 1 month after lumbar spine injections. Student t and x2 tests were used for statistical analysis.
Results: The mean effective participant dose for fluoroscopy-guided lumbar transforaminal epidural injections was 0.24 mSv 6 
0.22, compared with 0.33 mSv 6 0.10 for CT-guided injections (P , .003). The mean effective participant dose for fluoroscopy-
guided lumbar facet joint injections was 0.10 mSv 6 0.11, compared with 0.33 mSv 6 0.13 for CT-guided injections (P , .001). 
Radiation exposure for the interventionalist was higher during fluoroscopy-guided compared with CT-guided lumbar transforami-
nal epidural injections (body: 0.42 3 1023 mSv 6 0.99 vs 0.11 3 1023 mSv 6 0.44, P , .03; wrist: 1.44 3 1023 mSv 6 2.69 
vs 0.14 3 1023 mSv 6 0.55, P , .001). Radiation exposure of the wrist for the interventionalist was higher during fluoroscopy-
guided compared with CT-guided lumbar facet injections (0.46 3 1023 mSv 6 0.93 vs 0.06 3 1023 mSv 6 0.24, respectively; P , 
.006). Clinical participant outcomes as determined with the PGIC scale did not differ between fluoroscopy-guided and CT-guided 
injections (P = .15–.96).
Conclusion: Radiation exposure in fluoroscopy-guided lumbar spinal injections was lower for participants and higher for physicians 
when compared with CT-guided injections; however, no associations were observed between clinical participant outcomes and type 
of imaging-guided injection technique at all evaluated time points.
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Patients were excluded if they were at a greater risk of bleeding 
according to published considerations for the management of 
anticoagulation medication in interventional musculoskeletal 
radiology procedures (9). Moreover, we excluded postsurgical 
patients with metallic implants of the spine, patients referred 
for lumbar spinal injections of two or more segments, patients 
referred for injection to sites other than the lumbar spine, preg-
nant patients, and patients younger than 18 years.
Participant assignment to either fluoroscopy-guided or 
CT-guided lumbar spine injection was predominantly de-
pendent on the point in time: Until August 2014, almost 
every participant referred for lumbar spinal injection was 
assigned to undergo a fluoroscopy-guided injection proce-
dure. A second CT scanner with the possibility of a low 
tube current of 8 mAs was newly installed during the sum-
mer of 2014 at our institution due to a capacity shortage 
in both fluoroscopy-guided and CT-guided interventional 
musculoskeletal procedures. Starting from August 2014, 
most lumbar spinal injections were performed as CT-guided 
Abbreviation
PGIC = Patient Global Impression of Change
Summary
Radiation exposure in fluoroscopy-guided lumbar spinal injections 
is lower for patients and higher for physicians when compared with 
CT-guided injections; however, no associations were observed be-
tween patient outcomes and type of imaging-guided injection.
Implications for Patient Care
 n The mean effective radiation dose for patients is lower for fluoros-
copy-guided compared with CT-guided lumbar spinal injections.
 n The mean radiation exposure for interventionalists is higher during 
fluoroscopy-guided compared with CT-guided lumbar transfo-
raminal epidural and lumbar facet joint injections.
 n The imaging-guided injection technique, whether fluoroscopy- or 
CT-guided, did not have an impact on patient outcomes.
(Figs 1–3). The mean participant age was 60.6 years (range, 
18–91 years). The mean age of women was 62.5 years (range, 
18–91 years), and the mean age of men was 58.3 years (range, 
18–90 years).
Participant and physician radiation exposures were measured 
during fluoroscopy-guided and CT-guided lumbar transforami-
nal epidural injections and lumbar facet joint steroid injections 
in 199 participants (fluoroscopy-guided lumbar transforaminal 
epidural injections: n = 55; CT-guided lumbar transforaminal 
epidural injections: n = 70; fluoroscopy-guided lumbar facet 
joint injections: n = 24; CT-guided lumbar facet joint injections: 
n = 50).
Participants’ outcomes after therapeutic fluoroscopy-guided 
and CT-guided lumbar transforaminal epidural and lumbar 
facet joint steroid injections were obtained in 1247 participants 
(fluoroscopy-guided lumbar transforaminal epidural injections: 
n = 449; CT-guided lumbar transforaminal epidural injections: 
n = 199; fluoroscopy-guided lumbar facet joint injections: n = 
390; CT-guided lumbar facet joint injections: n = 209).
The medical history and physical examination for each par-
ticipant was performed by orthopedic surgeons and rheuma-
tologists. The imaging-guided lumbar spinal injection proce-
dures were indicated and requested by orthopedic surgeons and 
rheumatologists on the basis of the participant’s medical history, 
symptoms, and clinical and medical imaging findings. Lumbar 
transforaminal epidural injections were indicated in patients 
with radicular pain due to nerve root compression without mo-
tor deficits (7). Lumbar facet joint steroid injections were indi-
cated in patients with nonradicular low back pain due to osteo-
arthritis of the lumbar facet joints (7).
Our study inclusion criteria were participant referral to a 
single-center academic radiology department for a single lum-
bar segment steroid injection procedure including the L5-S1 
facet joint and participant inclusion in the outcomes database 
for imaging-guided therapeutic musculoskeletal injections of 
the University Hospital Balgrist. As part of a convenience se-
ries, each patient undergoing an imaging-guided lumbar spinal 
injection since October 2009 was invited as a participant in 
the outcomes database of the University Hospital Balgrist (8). 
Figure 1: Flowchart of participant inclusion for transforami-
nal epidural steroid injections. A total of 5929 participants 
underwent imaging-guided transforaminal epidural steroid 
injections between October 2009 and April 2016. Of those 
5929 participants, 2376 were excluded because they received 
nonlumbar transforaminal epidural steroid injections, 359 
because they received multisegmental injections, and 489 be-
cause they received steroid injections other than triamcinolone 
acetonide. A total of 648 participants underwent lumbar trans-
foraminal epidural injections and returned clinical outcomes 
questionnaires.
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Fluoroscopy Protocol
All fluoroscopy-guided therapeutic injections were performed 
with a digital fluoroscopy system with a 43 3 43-cm flat-panel 
detector (Ultimax-i Modell Drex-U180; Toshiba Medical 
Systems, Otawara, Tochigi, Japan) by using real-time pulsed 
fluoroscopy at 3.75 images per second with last image hold 
without digital subtraction technique. Standard preselected ex-
posure parameters were 40 mA for tube current and 80 kVp for 
the tube voltage; however, these parameters were modulated by 
the automatic exposure control. The needle tip was guided to 
the intervertebral foramen by using biplanar anteroposterior-
oblique and lateral projections for fluoroscopy-guided transfo-
raminal epidural steroid injection. Lumbar facet joint steroid 
injections were exclusively performed in the anteroposterior 
x-ray beam projection.
CT Protocol
All CT-guided spinal injections were performed with one 
64-channel multidetector CT scanner (Somatom Definition 
AS; Siemens Healthineers, Erlangen, Germany). A monopla-
nar CT scout view was obtained in the lateral projection (tube 
current: 60 mAs, peak voltage: 120 kVp), followed by a spiral 
CT scan (tube current: 50 mAs, peak voltage: 100 kVp), as 
preparation for the injection. The preinjection CT images were 
limited to the lumbar spine segments of interest to minimize 
the radiation exposure. The needle puncture site on the skin 
was selected on the sections of the initial spiral CT scan.
Sequential mode CT images with a section thickness of 2.4 
mm (i-sequence, tube current: 8 mAs, peak voltage: 120 kVp) 
were used for tracking the injection needle path during the pro-
cedure and for the final scan to document the iodinated contrast 
agent distribution (10).
Injection Procedures
One of eight fellowship-trained musculoskeletal radiologists 
from the University Hospital Balgrist performed fluoroscopy-
guided and CT-guided transforaminal epidural and 
lumbar facet joint steroid injections (T.J.D., S.B., 
R.S., C.W.A.P., with 7, 3, 7, and 18 years of expe-
rience, respectively, with dedicated musculoskeletal 
radiology and four additional radiologists with 4–9 
years of experience with dedicated musculoskeletal 
radiology). Each radiologist performed all types 
of procedures, without individual preferences for 
fluoroscopy-guided or CT-guided injections. Par-
ticipants were positioned in the prone position. 
Injection needles with a diameter of 20 gauge and 
a length of 7 cm and a diameter of 22 gauge and 
lengths of 11 or 15 cm were used for application of 
the drugs. An 18-gauge-diameter, 4-cm-long coax-
ial introducer needle reinforced the 22-gauge injec-
tion needles. An infraneural approach or supraneu-
ral, so-called safe triangle, approach with the needle 
tip adjacent to the intervertebral foramen was used 
for transforaminal epidural steroid injections (6,11) (Figs 4, 5). 
A direct dorsal approach was used for lumbar facet joint steroid 
injections. Fluoroscopic images in the fluoroscopy-guided group 
injections with use of the new CT scanner. However, some 
participants and referring physicians still preferred fluoros-
copy-guided lumbar spinal injections.
Figure 2: Flowchart of participant inclusion for facet joint ste-
roid injections. A total of 4135 participants underwent imaging-
guided facet joint steroid injections between October 2009 and 
April 2016. Of those 4135 participants, 594 were excluded 
because they received nonlumbar facet joint steroid injections, 
1874 because they received multisegmental injections, 138 be-
cause they received steroid injections other than triamcinolone 
acetonide, and two because they were younger than 18 years. 
A total of 599 participants underwent lumbar facet joint steroid 
injections and returned clinical outcomes questionnaires.
Figure 3: Flowchart shows two cohorts of participants (Part.) receiving transforam-
inal epidural injections or facet joint injections under fluoroscopic or CT guidance. 
In one cohort, radiation exposure was assessed for participants and interventional-
ists. In the other cohort, outcome measurements were assessed by using the Patient 
Global Impression of Change (PGIC ) scale.
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to keep the radiation exposure as low as achievable for both 
participants and interventionalists. The technologist was not 
inside the fluoroscopy or CT rooms while fluoroscopic images 
or spiral CT scans were obtained. The size of the fluoroscopic 
image was restricted to the smallest reasonable area. Magnifica-
tion views were obtained at the discretion of each intervention-
alist. To minimize radiation exposure, the interventionalist did 
not position his or her wrists or fingers within the x-ray beam 
during image acquisition.
A plastic forceps served as an extension for the hand and fin-
gers of the interventionalist during needle guidance so that the 
hand and fingers were not in the path of the x-rays. If technically 
feasible, the interventionalist briefly left the fluoroscopy room 
for some of the image acquisitions and went to the control room 
to observe the ALARA principle (Fig 6). For CT procedures, the 
interventionalist’s preferable position was at the side of the gan-
try for most of the image acquisitions because it is known that 
radiation exposure tends to be below a measurable threshold at 
this particular location within the CT room itself (12,13) (Fig 
6). The interventionalist stayed within the CT room during the 
injection procedure, including the acquisition of the CT images, 
to track the injection needle path. The interventionalist was in 
the CT control room during acquisition of the CT scout view 
and spiral CT scan used to prepare for the injection. An x-ray 
radiation-shielding screen was not available in either the fluoros-
copy room or the CT room.
Conversion Factor
The effective dose (in millisieverts) was established by using 
conversion factors from International Commission on Radio-
logical Protection publication 103 recommendations (14). 
The effective dose for fluoroscopy-guided procedures was es-
timated by multiplying the conversion factor of 0.23 mSv · 
Gy21 · cm22 by the dose-area product (in Gy · cm2) displayed 
and CT images in the CT-guided group were obtained after 
iodinated contrast agent injection (iopamidol, 200 mg/mL) to 
confirm the correct needle tip location. Contrast agent drainage 
on these fluoroscopic or postinjection CT images was indicative 
of an intravascular position; as a consequence, the needle tip lo-
cation was corrected. Subsequently, a lumbar transforaminal epi-
dural injection or facet joint injection was performed with use 
of local anesthetics (1 mL ropivacaine 0.2% [Naropin; Astra-
Zeneca, Södertälje, Sweden]) and long-acting corticosteroids 
(40 mg triamcinolone acetonide [Triamcort; Helvepharm, 
Frauenfeld, Switzerland]). Interventionalists were asked to re-
spect the “as low as reasonably achievable,” or ALARA, concept 
Figure 4: Images in 50-year-old man with radicular pain who underwent fluoroscopy-guided lumbar transforaminal epidural 
injection. Postinjection (a) anteroposterior oblique and (b) lateral views demonstrate typical contrast agent distribution along 
left L5 lumbar nerve root.
Figure 5: Image in 64-year-old man with radicular pain who 
underwent CT-guided lumbar transforaminal epidural injection. 
Postinjection transverse CT image shows typical contrast agent 
distribution along right L5 lumbar nerve root.
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life related to your painful con-
dition?” The seven available an-
swers were (a) “much worse,” (b) 
“worse,” (c) “slightly worse,” (d) 
“no change,” (e) “slightly better,” 
(f ) “better,” and (g) “much bet-
ter.” Only the responses “better” 
and “much better” were consid-
ered as indicative of relevant im-
provement. Conversely, the re-
sponses “much worse,” “worse,” 
and “slightly worse” were con-
sidered indicative of relevant 
worsening. The responses “no 
change” and “slightly better” 
were interpreted as indicating 
no change (18,19). Participants 
were instructed to evaluate spe-
cifically the response to treat-
ment (injection procedure) for 
their major complaints of lower 
back pain or radicular pain.
Fifteen minutes after the 
lumbar spinal injection, the 
seven-option PGIC scale was explained to the participants. 
The participants were given 1-day, 1-week, and 1-month out-
come questionnaires along with a pre-addressed, stamped en-
velope. Participants were requested to return the completed 
questionnaires after the 1-month outcome time period.
Statistical Analysis
The unpaired Student t test was used to statistically compare 
the radiation exposure parameters related to fluoroscopy-
guided and CT-guided injection. The PGIC scale data were 
dichotomized into improved (yes or no) and worsened (yes or 
no). The percentage of participants who reported improve-
ment was compared with the proportion of participants who 
reported no improvement by using the x2 test (20). x2 analy-
ses were also performed for the parameters worsened and not 
worsened. P , .05 was considered to indicate a statistically 
significant difference between both groups and was calculated 
by using a statistical software package (SPSS for Windows, 
release 21.0; IBM, Armonk, NY).
Results
Participants
Tables 1 and 2 summarize participant demographic characteristics. 
No significant differences between fluoroscopy-guided and CT-
guided study group participants were observed with regard to age, 
height, weight, body mass index, and sex for both lumbar transfo-
raminal epidural injections and facet joint steroid injections.
Participants’ Radiation Dose Exposure
The mean effective dose for participants (Table 1) was significantly 
lower in the fluoroscopy-guided injection groups compared with 
the CT-guided injection groups (P , .003 and P < .001).
on the control panel of the fluoroscopy system (15). The effec-
tive dose for CT-guided injections was calculated by multiply-
ing the dose-length product (in mGy · cm) provided by the 
patient protocol of the CT scanner by the conversion factor of 
0.0127 mSv · mGy21 · cm21 (16).
Dosimeters
Two independent active personal dosimeters composed of 
a silicon-based detector (DoseGUARD S 10; NUVIA In-
struments, Dülmen, Germany) were used to monitor the 
radiation exposure to the interventionalist during the full 
duration of the procedure (17). The dosimeters fulfilled 
the requirements of the Physical Technical Federal Agency 
(Braunschweig, Germany). One dosimeter measured the 
radiation dose of the body and was fixed outside the lead 
gown at the level of the left breast. The second dosimeter 
measured the radiation exposure of the dominant hand and 
was worn like a wristwatch. The personal dosimeters were 
set to zero before each procedure and automatically dis-
played the measured radiation dose value in microsieverts 
(17). The measured radiation dose was noted in a database 
after each procedure.
Participant Outcomes Questionnaires
The Patient Global Impression of Change (PGIC) scale served as 
a reliable and validated participant outcomes assessment tool at 
1 day, 1 week, and 1 month after the therapeutic lumbar transfo-
raminal epidural injections and facet joint injections under fluo-
roscopic or CT guidance (18,19). The seven-item PGIC scale 
was used to measure the participant’s quality of life outcome af-
ter the injection. Participants were asked the following question: 
“Since your injection, how would you describe the change in 
activity limitations, symptoms, emotions, and overall quality of 
Figure 6: Illustration of imaging-guided injection techniques. Interventionalists stayed within fluoroscopy 
room (Position 1) or CT room (Position 1, Position 2) during injection procedures to track injection needle 
path. If technically feasible, interventionalists briefly left fluoroscopy room (Position 2) during fluoroscopy 
and went to control room to observe the “as low as reasonably achievable,” or ALARA, principle. For CT 
procedures, interventionalists’ preferable position was at the side of the gantry (Position 2) for most of the 
image acquisitions because radiation exposure tends to be below a measurable threshold at this location. 
CT technologists were not inside fluoroscopy or CT rooms during imaging-guided injections.
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scale were similar and did not differ significantly (P = .15–
.96) between the fluoroscopy-guided and CT-guided lumbar 
transforaminal epidural and facet joint steroid injections at 
any evaluated time point. The proportion of participants re-
porting clinically relevant improvement 1 month after lum-
bar transforaminal epidural injection was 47% (197 of 416) 
with fluoroscopic guidance and 49% (91 of 187) with CT 
guidance (P = .83). The corresponding proportion of par-
ticipants reporting clinically relevant improvement 1 month 
after lumbar facet joint injection was 34% (128 of 373) with 
fluoroscopic guidance and 37% (72 of 196) with CT guid-
ance (P = .63). The percentage of participants who reported 
clinically relevant worsening 1 month after lumbar transfo-
raminal epidural injection was 13% (55 of 416) with fluoro-
scopic guidance and 17% (32 of 187) with CT guidance (P = 
Interventionalists’ Radiation Dose Exposure
The radiation exposure of the body and the wrist for the inter-
ventionalist (Table 1) was significantly higher during fluoroscopy-
guided compared with CT-guided lumbar transforaminal epidural 
injections (P , .03). Moreover, the radiation exposure of the wrist 
for the interventionalist was significantly higher during fluoros-
copy-guided compared with CT-guided lumbar facet joint steroid 
injections (P , .006). The radiation exposure of the body for the 
interventionalist was also higher during fluoroscopy-guided com-
pared with CT-guided lumbar facet joint injections; however, the 
difference was not statistically significant (P = .08).
Participants’ Outcomes
Table 2 shows that the proportions of participants who re-
ported improvement and worsening with use of the PGIC 
Table 1: Radiation Exposure to Participants and Interventionalists from Fluoroscopy-guided and CT-guided Lumbar 
Transforaminal Epidural and Lumbar Facet Joint Steroid Injections
Parameter
Lumbar Transforaminal Epidural Injection Lumbar Facet Joint Steroid Injection
Fluoroscopy-guided  
Injection (n = 55)*
CT-guided Injection  
(n = 70)* P Value
Fluoroscopy-guided  
Injection (n = 24)*
CT-guided Injection  
(n = 50)* P Value
Participants
 Age (y) 56.4 6 15.8 61.3 6 13.6 .06 66.0 6 11.6 59.8 6 16.7 .10
 Height (cm) 171.1 6 9.8 167.8 6 8.9 .05 168.9 6 8.2 170.1 6 9.4 .60
 Weight (kg) 80.9 6 14.9 79.0 6 14.9 .47 80.3 6 15.8 79.6 6 17.5 .87
 Body mass index (kg/m2) 27.7 6 4.6 28.1 6 5.4 .63 28.0 6 3.9 27.5 6 5.7 .71
 Radiation exposure:  
  effective dose (mSv)
0.24 6 0.22 0.33 6 0.10 ,.003† 0.10 6 0.11 0.33 6 0.13 ,.001†
Interventionalists
 Radiation exposure:  
  body (mSv)
0.42 3 1023 6 0.99 0.11 3 1023 6 0.44 ,.03† 0.38 3 1023 6 1.1 0.08 3 1023 6 0.27 .08
 Radiation exposure:  
  wrist (mSv)
1.44 3 1023 6 2.69 0.14 3 1023 6 0.55 ,.001† 0.46 3 1023 6 0.93 0.06 3 1023 6 0.24 ,.006†
* Numbers are means 6 standard deviations.
† Statistically significant.
Table 2: Participant Outcomes after Fluoroscopy-guided and CT-guided Lumbar Transforaminal Epidural and Lumbar 
Facet Joint Steroid Injections
Parameter
Lumbar Transforaminal Epidural Injection Lumbar Facet Joint Steroid Injections
Fluoroscopy-guided  
Injection (n = 449)
CT-guided Injection  
(n = 199) P Value
Fluoroscopy-guided  
Injection (n = 390)
CT-guided Injection  
(n = 209) P Value
Mean age (y) 61.2 6 15.1 60.5 6 14.4 .55 60.3 6 14.0 60.0 6 12.8 .77
M:F ratio 233:216 101:98 .66 149:241 88:121 .40
Improved at 1 d 143/446 (32) [28–36] 69/197 (35) [28– 42] .52 133/385 (35) [30–39] 60/207 (29) [23–35] .20
Improved at 1 wk 174/439 (40) [35– 44] 90/195 (46) [39–53] .15 145/382 (38) [33– 43] 79/204 (39) [32– 45] .93
Improved at 1 mo 197/416 (47) [43–52] 91/187 (49) [41–56] .83 128/373 (34) [29–39] 72/196 (37) [30– 43] .63
Worse at 1 d 47/446 (11) [8–13] 22/197 (11) [7–16] .92 39/385 (10) [7–13] 25/207 (12) [8–17] .56
Worse at 1 wk 54/439 (12) [9–15]) 23/195 (12) [7–16] .96 43/382 (11) [8–14] 30/204 (15) [10–20] .28
Worse at 1 mo 55/416 (13) [10–16] 32/187 (17) [12–23] .26 66/373 (18) [14 –22] 42/196 (21) [16–27] .33
Note.—Outcomes were based on the Patient Global Impression of Chance (PGIC) scale. Except where indicated, numbers are raw data, 
with the numerator indicating the number of participants with clinically relevant improvement or relevant worsening according to the 
PGIC scale and the denominator indicating the number of participants who returned the outcome questionnaire. Numbers in parentheses 
are the percentage of participants who reported clinically relevant improvement or relevant worsening. Numbers in brackets are the lower 
and upper limits of 95% confidence intervals.
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the PGIC scale 1 month after imaging-guided lumbar trans-
foraminal epidural injections. More than one-third of all 599 
participants reported clinical improvement on the PGIC scale 
1 month after imaging-guided lumbar facet joint injections.
Maino et al (4), in a retrospective study, found that the patient 
radiation dose exposure for fluoroscopy-guided lumbar spine in-
jections was approximately eight times lower than that for CT-
guided lumbar spine injections. However, a possible study bias 
arose from the fact that the authors retrospectively compared 
fluoroscopy-guided lumbar spine injections from their own ser-
vice against CT-guided lumbar spine injections performed by 
radiologists at six various institutions across the same country.
A low radiation exposure for participants and interventional 
physicians according to the ALARA principle as well as a safe 
approach is mandatory for any imaging-guided procedure. Al-
though clinically guided, US-guided, and MRI-guided lumbar 
injection therapies with long-acting steroids are described in 
the literature, most physicians worldwide, including the staff 
at our institution, feel more confident regarding patient safety 
with fluoroscopy-guided and CT-guided lumbar spinal injec-
tion techniques in a daily clinical routine (6,21–24). Physicians 
are obliged to reduce the radiation exposure as low as possible. 
Thus, the applied standard fluoroscopy and CT protocols in our 
study were adjusted as described earlier according to the ALARA 
principle. Fluoroscopy-guided lumbar spine injections necessi-
tate real-time manual guidance and manipulation of the needles; 
thus, the body, wrist, and hand of the interventionalist is ex-
posed to scattered radiation due to the proximity of the primary 
x-ray beam (25). Conversely, CT-guided lumbar spine injections 
frequently allow steering and manipulation without simultane-
ous verification of the needle location by the x-ray beam (12). 
Thus, the radiation exposure for the body and wrist of the inter-
ventionalist was significantly higher during fluoroscopy-guided 
compared with CT-guided lumbar spinal injections in our study. 
Another advantage of CT-guided spinal injections is that the in-
terventionalist may leave the CT room and stop in the control 
room during image acquisition to minimize the radiation expo-
sure (26).
This study had limitations. First, we used an observational 
study design, with nonrandomized sequential participant as-
signment to either a fluoroscopy-guided or CT-guided lumbar 
spine injection procedure predominantly dependent on the 
injection date. In addition, an indirect technique (dose-area 
product and dose-length product measurements) was used to 
estimate effective radiation dose in participants instead of di-
rect radiation exposure quantification techniques with dosim-
eters. However, the use of participant dosimeters to estimate 
the effective radiation dose was determined to be impractical 
in our study. The effective dose concept was developed to es-
timate radiation side effects for the uniform equivalent dose 
to the whole body on the basis of a population of all ages and 
both sexes. Several uncertainties were expressed in the calcu-
lation and appliance of effective doses related to fluoroscopic 
procedures and CT for individual patients (27). In contrast, 
we used effective doses for the comparison of the amount of 
radiation dose exposure. Active personal dosimeters were used 
in our study. The International Atomic Energy Agency found 
.26). The corresponding proportion of participants reporting 
clinically relevant worsening 1 month after lumbar facet joint 
injection was 18% (66 of 373) with fluoroscopic guidance 
and 21% (42 of 196) with CT guidance (P = .33).
Interim Treatments
Eight participants from the fluoroscopy-guided group and one 
participant from the CT-guided group received interim treat-
ments within the 1-month observation period after lumbar 
transforaminal epidural injections: All but one of the nine par-
ticipants underwent lumbar spinal surgery, whereas one par-
ticipant from the fluoroscopy-guided group underwent lumbar 
facet joint injections subsequent to the evaluated lumbar trans-
foraminal epidural injection. Notably, these nine participants 
returned the outcome questionnaires; however, the 1-month 
PGIC scale was not filled out by any of these nine participants 
after interim treatments within the 1-month observation pe-
riod subsequent to lumbar transforaminal epidural injections.
Seven participants in the fluoroscopy-guided group received 
interim treatments within the 1-month observation period af-
ter lumbar facet joint injections: Two participants underwent 
lumbar spinal surgery and reported relevant worsening on the 
1-month PGIC scale, one participant received facet joint injec-
tions in the adjacent L5-S1 segment, two participants received 
repeat lumbar facet joint injections at the same level, one partici-
pant underwent lumbar interlaminar epidural steroid injection, 
and one participant received systemic steroid treatment and re-
ported no change on the 1-month PGIC scale subsequent to flu-
oroscopy-guided lumbar facet joint injections. Notably, all four 
participants who underwent repetition of any type of imaging-
guided injection therapy returned the outcome questionnaires; 
however, the 1-month PGIC scale was not filled out by these 
participants after lumbar facet joint injections. No participant 
of the CT-guided group received interim treatments within the 
1-month observation period after lumbar facet joint injections.
Discussion
In our study, the participant radiation dose exposure was 1.4 
times lower for fluoroscopy-guided compared with CT-guided 
lumbar transforaminal epidural injections and 3.3 times lower 
for fluoroscopy-guided compared with CT-guided lumbar 
facet joint steroid injections. Conversely, the radiation expo-
sure to the body and wrist of the interventional physicians was 
between 3.7 times and 10 times higher for fluoroscopy-guided 
compared with CT-guided lumbar spine injections. It must be 
noted that the amount of radiation dose exposure for partici-
pants was determined with multiplication of established con-
version factors, whereas the amount of radiation dose exposure 
for interventionalists was measured with two independent ac-
tive personal dosimeters.
Remarkably, the clinical outcomes of the large study cohort 
of 1247 participants were similar at all evaluated time points 
up to 1 month, without statistically significant differences be-
tween the fluoroscopy-guided technique and the CT-guided 
therapeutic lumbar spine steroid injections with local anes-
thesia and long-acting corticosteroids. In our study, almost 
half of the 648 participants reported clinical improvement on 
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that the general performance of active personal dosimeters is 
comparable to that of standard passive dosimetric systems (28). 
These active personal dosimeters provide a satisfactory energy 
and angular response and are increasingly used for measure-
ments of occupational exposure in the field of interventional 
radiology (29). However, active personal dosimeters may un-
derestimate the radiation exposure in pulsed radiation such as 
pulsed fluoroscopy, which was used in the present study (29). 
Another limitation is the fact that interim treatments in some 
participants may have led to a confounding factor. However, 
such a treatment was rare in this study population within the 
1-month observation period and was only seen in 16 of the 
1247 participants (1.3%), and only three participants who 
underwent interim treatment (0.2%) filled out the 1-month 
PGIC questionnaires. Thus, the resulting confounding factor 
due to interim treatment was considered minimal. Finally, a 
lack of statistical significance between the imaging-guided par-
ticipant groups with regard to clinical outcomes does not prove 
equivalence (30).
In summary, radiation exposure in fluoroscopy-guided lum-
bar spinal injections was significantly lower for participants and 
higher for physicians when compared with CT-guided injections 
and vice versa; however, no associations were observed between 
clinical participant outcomes and type of imaging-guided injec-
tion technique at all evaluated time points.
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